Viatris (VTRS) Operating Expenses (2019 - 2026)
Viatris (VTRS) recorded quarterly Operating Expenses of $1.2 billion in Q1 2026, down 7.74% quarter-over-quarter from $1.3 billion in Q4 2025, and down 69.41% on a YoY basis from $4.0 billion in Q1 2025.
Viatris (VTRS) Operating Expenses (2019 - 2026) Analysis & Trends
Viatris' Operating Expenses history runs 8 years deep, the most recent figure standing at $1.2 billion for Q1 2026.
- In Q1 2026, Operating Expenses fell 69.41% year-over-year to $1.2 billion; the TTM figure through Mar 2026 stood at $4.9 billion (down 41.72% YoY), while the FY2025 annual figure was $7.7 billion, up 36.75% from the prior year.
- Operating Expenses was $1.2 billion for Q1 2026 at Viatris, down from $1.3 billion in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $4.0 billion in Q1 2025 to a low of $1.1 billion in Q1 2022.
- Historically, Operating Expenses has averaged $1.5 billion across 5 years, with a median of $1.2 billion in 2023.
- The sharpest annual moves came in 2025 and 2026: Operating Expenses surged 211.01% in 2025, then slumped 69.41% in 2026.
- A 5-year view of Operating Expenses shows it stood at $1.5 billion in 2022, then jumped by 39.01% to $2.1 billion in 2023, then tumbled by 31.99% to $1.4 billion in 2024, then dropped by 3.89% to $1.3 billion in 2025, then declined by 7.74% to $1.2 billion in 2026.
- The last three Operating Expenses figures came in at $1.2 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 526.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 788.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 455.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 19.40 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 621.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 478.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 441.19 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 96.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 475.11 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 1.24 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.24 Bn |
| Dec 31, 2025 | 1.34 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.10 Bn |
| Mar 31, 2025 | 4.04 Bn |
| Dec 31, 2024 | 1.39 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.69 Bn |
| Mar 31, 2024 | 1.30 Bn |
| Dec 31, 2023 | 2.05 Bn |
| Sep 30, 2023 | 1.24 Bn |
| Jun 30, 2023 | 1.24 Bn |
| Mar 31, 2023 | 1.14 Bn |
| Dec 31, 2022 | 1.48 Bn |
| Sep 30, 2022 | 1.19 Bn |
| Jun 30, 2022 | 1.15 Bn |
| Mar 31, 2022 | 1.06 Bn |
| Dec 31, 2021 | 1.62 Bn |
| Sep 30, 2021 | 1.22 Bn |
| Jun 30, 2021 | 1.38 Bn |